Further validation of the IBS-QOL: Female Mexican IBS patients have poorer quality of life than females from North Carolina

Digestive Diseases and Sciences

Volumn 52, Issue 11, 2007, Pages 2950-2955

  Schmulson, Max ^a,f   Ortiz, Orianna ^b   Mejia Arangure, Juan Manuel ^c   Hu, Yuming B ^d   Morris, Carolyn ^d   Arcila, Denise ^e   Gutierrez Reyes, Gabriela ^a   Bangdiwala, Shrikant ^d   Drossman, Douglas A ^d  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c HOSPITAL DE PEDIATRÍA   (Mexico)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^f HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

Health related quality of life (HRQOL); IBS QOL; Irritable bowel syndrome; Mexico; North Carolina; Validation

Indexed keywords

ADULT; ARTICLE; BODY IMAGE; CONSTRUCT VALIDITY; CONTROLLED STUDY; DEFECATION HABIT; DYSPHONIA; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MEXICO; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; SCORING SYSTEM; UNITED STATES;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRRITABLE BOWEL SYNDROME; MEXICO; NORTH CAROLINA; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 34848843203     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9689-9     Document Type: Article

References (26)

1. Testa MA, Simonson DC (1996) Assessment of quality of life outcomes. N Engl J Med 334:835-840
2. Eisen GM, Locke GR III, Provenzale D (1999) Health-related quality of life: a primer for the gastroenterologists. Am J Gastroenterol 94:2017-2021
3. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA (2000) The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 119:654-660
4. Schmulson M, Robles G, Kershenobich D, López RR, Hinojosa CA, Duarte CA, Bandera J (2000) Los pacientes con trastornos funcionales digestivos (TFD) tienen mayor compromiso de la calidad de vida (CV) evaluada por el SF-36 comparados con pacientes con hepatitis C y pancreatitis crónica. Rev Gastroenterol Méx 65 (Suppl 1):50
5. Chang L (2004) Review article: Epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 20 (Suppl 7):31-39
6. Patrick DL, Drossman D, Frederick IO, Dicesare J, Puder KL (1998) Quality of life in persons with irritable bowel syndrome. Development and validation of a new measure. Dig Dis Sci 43:400-411
7. Drossman DA, Patrick DL, Whitehead WE, Toner BD, Diamant NE, Hu Y, Jia H, Bangdiwala SI (2000) Am J Gastroenterol 95:999-1007
8. Acquadro C, Conway K, Giroudet C, Mear I (2004) Linguistic validation manual for patient-reported outcomes (PRO) instruments. MAPI Research Institute, Lyons, France
9. Bijkerk CJ, de Wit NJ, Muris JWM, Jones RH, Knottnerus JA, Hoes AW (2003) Outcome measures in irritable bowel syndrome: Comparison of psychometric and methodological characteristics. Am J Gastroenterol 98:122-127
10. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370
11. López-Alvarenga JC, Vzquez-Velzquez V, Arcila-Martínez D, Sierra-Ovando AE, Gonzles-Barranco J, Salín-Pascual RJ (2002) Exactitud y utilidad diagnóstica del Hospital Anxiety and Depresión Scale (HAD) en una muestra de sujetos obesos mexicanos. Rev Invest Clin 54:403-409
12. Thompson WG, Working Team for Functional Bowel Disorders (1994) Functional bowel disorders and functional abdominal pain. In: The functional gastrointestinal disorders. Drossman DA, Richter JE, Talley NJ, Thompson WG, Corazziari E, Whitehead WE (eds). Little, Brown, Boston, pp 115-173
13. Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Leserman J, Shetzline M, Dalton C, Bangdiwala SI (2005) A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternative. Gastroenterology 128:580-589
14. American College of Gastroenterology Functional Gastrointestinal Disorders Task Force (2002) Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol 97(Suppl):S1-S5
15. Bergman JF, Chassany O (1998) The role of quality of life in functional gastrointestinal disorders: regulatory issues. Eur J Surg 83(Suppl 5):87-91
16. Zuniga MA, Carrillo-Jimenez GT, Fos PJ, Gandek B, Medina-Moreno MR (1999) Evaluación del estado de salud con la encuesta SF-36: resultados preliminares en México. Salud Publica Mex 41:110-118
17. Schmulson M, Ortiz O, Hinojosa C, Arcila D (2006) A single session of reassurance can acutely improve the self-perception of impairment in patients with IBS. J Psychosom Res (in press)
18. Koloski NA, Talley NJ, Boyce PM (2000) The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 95:67-71
19. Badia X, Mearin F, Balboa A (2002) Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics 20:749-758
20. Halder SL, Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd (2004) Impact of functional gastrointestinal disorders on health related quality of life: a population-based case-control study. Aliment Pharmacol Ther 19:233-242
21. Frank L., Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C (2002) Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther 24:675-689
22. Kellow J, Lee OY, Chang FY, Thongsawat S, Mazlam MZ, Yuen H, Gwee KA, Bak YT, Jones J, Wagner A (2003) An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut 52:671-676
23. Schmulson M, Remes JM, Olivas T, Valdovinos MA, Hinojosa C, Chang L, Mayer E, Naliboff B (2003) Clinical characteristics and QOL in IBS patients from Mexico and the USA: Are they different? Gastroenterology 124 (Suppl 1):A-395
24. Carr AJ, Gibson B, Robinson PG (2001) Measuring quality of life. Is quality of life determined by expectations or experience? BMJ 322:1240-1243
25. Park MI, Camilleri M (2005) Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment. Gastroenterol Clin North Am 34:305-317
26. Hahn BA, Ya S, Strassels S (1999) Impact of irritable bowel syndrome in the United States and United Kingdom. Digestion 60:77-81